Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.80 -1.94% 91.20 91.20 91.60 93.20 90.00 93.20 1,110,595 15:12:53
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -29.4 -36.8 - 120

4d Pharma Share Discussion Threads

Showing 12826 to 12843 of 15600 messages
Chat Pages: Latest  516  515  514  513  512  511  510  509  508  507  506  505  Older
DateSubjectAuthorDiscuss
25/10/2020
12:53
Not one product at phase 3 and revenue generating phase.Caution with applying unrealistic valuations.I'm long and looking to build a position but Nasdaq listing is not the golden ticket.Many UK Biopharmas have taken this route and failed.Ultimately it will be viable and theraputic Biome bacteria that will drive value here.
rastamouse
25/10/2020
12:49
Patents doesn't necessarily equate to value Its the value and revenue successful Patents command.So its how many of these patents will be successful not the number of registered patents.Comparison to Seres at this current moment in time (and DDDDs product development cycle) is totally unrealistic.Yes, an appreciation in value on listing to Nasdaq is possible but not guaranteed.
rastamouse
25/10/2020
12:43
https://twitter.com/lramseu/status/1320312359752269825?s=21https://twitter.com/lramseu/status/1320323025645019138?s=21Have a look at these charts
hodr
25/10/2020
12:42
How many patents has Seres, compared to 4Ds 1000 plus and counting. True not that simple as a like for like case, but in this field 4d leads.
royalalbert
25/10/2020
12:41
4D world leaders in live biotherapeutics. 4D has platform approach, better pipeline(16 lines), bigger markets, large deal ($1b+), more patents, superior collaboration (mrk) & strategic partnership (MD Anderson) world leader oncology. 4D significantly more progressed & developed than their peers.4D has consistently delivered & achieved all goals to date. Unlike Seres, failed P2. 4D's proprietary discovery platform, MicroRx®, is focussed on understanding & exploiting bacteria functionality - Discover, Develop, Protect & Prove.
hodr
25/10/2020
12:35
Seres also has revenues of USD 36 million.DDDD revenue just over 200k sterling.So again the comparisons need clarification (in terms of why DDDD should have an equivalent valuation to Seres).CEO in his podcast made the same point, he felt DDDD valuation should be much higher (made reference to 2 billion valuations on Nasdaq, I'm assuming he was referring to Seres).Valuation parity can be expected on positive results, collaborations and significantly higher revenues from DDDD.I'm assuming some here feel that will come with time.
rastamouse
25/10/2020
12:24
Question.Many here talk about the valuation disparity between DDDD Sterling175 million and Nasdaq listed Seres Theraputics USD 2.5 billion.Now surely its not a simple fact that one is on AIM the other on Nasdaq.I'm assuming Seres has more cash, backers and products further down the product life cycle.Yes, listing to Nasdaq should add value to DDDD but the difference in valuation is not simply down to being listed on different exchanges.I'm happy to be proved wrong.
rastamouse
25/10/2020
12:21
Think he's still looking for the gap at 80p...
ozzywalker
25/10/2020
09:46
With such a significant drop recently followed by recovery, I find it useful to recap, reading through the past 2 weeks posts shows quite a picture of those whom post with sincerity, knowledge and honesty and those that have lost all credibility, with either no knowledge or deliberate actions to mislead....a good read for any new arrivals....
daveweld2
25/10/2020
08:46
Https://youtu.be/AwS7JaWB0x8 Katsy started watching that Incke video but preferred the one above
saint in exile
24/10/2020
21:13
Seeeen..Weed gives me clarity of vision and calmness of the mind.The heavenly herb is da only way during these raaas claat times.Peace out
rastamouse
24/10/2020
20:41
Here me now rastamouse, you got da big massive in da house. These bad boy shares are going to da moon. Chill on a pill, don't smoke da dope.
rastarat
24/10/2020
20:21
Cracky baccy is telling me to vomit right now RastaRat! Me and my gran, we’ze dun.
slippery gollem
24/10/2020
19:52
so sumutroll 4d pharma was a 10pound a share had 8 placings will run out of cash in early 2021 question the mkt cap is 178 million what are the profits and what are the p/e year on year ? looooooooooooooooooooooooooooooool
manc10
24/10/2020
19:44
jolly good show frrinvest and Mr Roper. Feeling jolly good today Stigo or a cuck? No idea what a cuck is. jolly jolly jolly.
jollychap
24/10/2020
18:28
This was a David Icke (Not a fan) lecture back in 2016. Worth watching and put into context of what is happening across the globe with Covid and the destruction of economies and the control of people. Scary hxxps://altcensored.com/watch?v=bMeXSlGJZYc
katsy
24/10/2020
17:43
I will be mostly accumulating here.The weed high is telling me to add.Peace out.
rastamouse
24/10/2020
13:33
LoL, does read that way I suppose.
royalalbert
Chat Pages: Latest  516  515  514  513  512  511  510  509  508  507  506  505  Older
ADVFN Advertorial
Your Recent History
LSE
DDDD
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201202 15:31:09